Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells

Anesthesiology

Volumn 113, Issue 4, 2010, Pages 906-916

  Sepac, Ana ^a   Sedlic, Filip ^b   Si Tayeb, Karim ^a   Lough, John ^a   Duncan, Stephen A ^a   Bienengraeber, Martin ^a   Park, Frank ^b   Kim, Jinhee ^a   Bosnjak, Zeljko J ^a  

^a Department of Anesthesiology ^*

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN 4; ENHANCED GREEN FLUORESCENT PROTEIN; HYDROGEN PEROXIDE; ISOFLURANE; LENTIVIRUS VECTOR; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MYOSIN LIGHT CHAIN; POTASSIUM CHANNEL; REACTIVE OXYGEN METABOLITE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; INHALATION ANESTHETIC AGENT;

ANTIBODY LABELING; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROTECTION; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEPOLARIZATION; DRUG MECHANISM; ELECTROPHYSIOLOGY; EMBRYONIC STEM CELL; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; CELL CULTURE; CELL MEMBRANE POTENTIAL; DRUG EFFECT; GENE VECTOR; GENETICS; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; IMMUNOHISTOCHEMISTRY; LENTIVIRINAE; METABOLISM; METHODOLOGY; MICRODISSECTION; PHYSIOLOGY;

ANESTHETICS, INHALATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; GENETIC VECTORS; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; KATP CHANNELS; LENTIVIRUS; MEMBRANE POTENTIALS; MICRODISSECTION; MICROSCOPY, CONFOCAL; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; OXIDATIVE STRESS; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES;

EID: 77957904668     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181eff6b7     Document Type: Article

References (46)

1. Zaugg M, Schaub MC: Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil 2003; 24:219-249
2. Stadnicka A, Marinovic J, Ljubkovic M, Bienengraeber MW, Bosnjak ZJ: Volatile anesthetic-induced cardiac preconditioning. J Anesth 2007; 21:212-219
3. van Laake LW, Hassink R, Doevendans PA, Mummery C: Heart repair and stem cells. J Physiol 2006; 577:467-478
4. Wobus AM, Boheler KR: Embryonic stem cells: Prospects for developmental biology and cell therapy. Physiol Rev 2005; 85:635-678
5. Caspi O, Itzhaki I, Kehat I, Gepstein A, Arbel G, Huber I, Satin J, Gepstein L: In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev 2009; 18:161-172
6. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108:407-414
7. Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R, Tertoolen L: Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003; 107:2733-2740
8. 2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 2006; 24:236-245
9. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ: Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circ Res 2003; 93:32-39
10. Laflamme MA, Zbinden S, Epstein SE, Murry CE: Cell-based therapy for myocardial ischemia and infarction: Pathophysiological mechanisms. Annu Rev Pathol 2007; 2:307-339
11. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, Yankelson L, Aronson D, Beyar R, Gepstein L: Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 2007; 50:1884-1893
12. Laflamme MA, Chen KY, Naumova AV Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25:1015-1024
13. Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ: Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway. ANESTHESIOLOGY 2009; 111:267-274
14. Raphael J, Abedat S, Rivo J, Meir K, Beeri R, Pugatsch T, Zuo Z, Gozal Y: Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther 2006; 318: 186-194
15. Huber I, Itzhaki I, Caspi O, Arbel G, Tzukerman M, Gepstein A, Habib M, Yankelson L, Kehat I, Gepstein L: Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J 2007; 21: 2551-2563
16. Henderson SA, Spencer M, Sen A, Kumar C, Siddiqui MA, Chien KR: Structure, organization, and expression of the rat cardiac myosin light chain-2 gene. Identification of a 250-base pair fragment which confers cardiac-specific expression. J Biol Chem 1989; 264:18142-18148
17. Zhu H, Garcia AV, Ross RS, Evans SM, Chien KR: A conserved 28-base-pair element (HF-1) in the rat cardiac myosin light-chain-2 gene confers cardiac-specific and alphaadrenergic- inducible expression in cultured neonatal rat myocardial cells. Mol Cell Biol 1991; 11:2273-2281
18. Park F: Correction of bleeding diathesis without liver toxicity using arenaviral-pseudotyped HIV-1-based vectors in hemophilia A mice. Hum Gene Ther 2003; 14:1489-1494
19. Park F, Sweeney WE, Jia G, Roman RJ, Avner ED: 20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease. J Am Soc Nephrol 2008; 19:1929-1939
20. Vanden Hoek TL, Shao Z, Li C, Schumacker PT, Becker LB: Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J Mol Cell Cardiol 1997; 29:2441-2450
21. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ: Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000; 192:1001-1014
22. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ: Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113: 1535-1549
23. Hüser J, Rechenmacher CE, Blatter LA: Imaging the permeability pore transition in single mitochondria. Biophys J 1998; 74:2129-2137
24. Hüser J, Blatter LA: Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem J 1999; 343:311-317
25. Mio Y, Bienengraeber MW, Marinovic J, Gutterman DD, Rakic M, Bosnjak ZJ, Stadnicka A: Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: Roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. ANESTHESIOLOGY 2008; 108:612-620
26. Ljubkovic M, Mio Y, Marinovic J, Stadnicka A, Warltier DC, Bosnjak ZJ, Bienengraeber M: Isoflurane preconditioning uncouples mitochondria and protects against hypoxiareoxygenation. Am J Physiol Cell Physiol 2007; 292: C1583-90
27. Kowaltowski AJ, Seetharaman S, Paucek P, Garlid KD: Bioenergetic consequences of opening the ATP-sensitive K(+) channel of heart mitochondria. Am J Physiol Heart Circ Physiol 2001; 280:H649 -57
28. Sedlic F, Pravdic D, Ljubkovic M, Marinovic J, Stadnicka A, Bosnjak ZJ: Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane. Anesth Analg 2009; 109:405-411
29. Hanouz JL, Zhu L, Lemoine S, Durand C, Lepage O, Massetti M, Khayat A, Plaud B, Gérard JL: Reactive oxygen species mediate sevoflurane- and desflurane-induced preconditioning in isolated human right atria in vitro. Anesth Analg 2007; 105:1534-1539
30. Snir M, Kehat I, Gepstein A, Coleman R, Itskovitz-Eldor J, Livne E, Gepstein L: Assessment of the ultrastructural and proliferative properties of human embryonic stem cellderived cardiomyocytes. Am J Physiol Heart Circ Physiol 2003; 285:H2355- 63
31. Kehat I, Gepstein A, Spira A, Itskovitz-Eldor J, Gepstein L: High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: A novel in vitro model for the study of conduction. Circ Res 2002; 91:659-661
32. Zhu WZ, Santana LF, Laflamme MA: Local control of excitation- contraction coupling in human embryonic stem cellderived cardiomyocytes. PLoS One 2009; 4:e5407.
33. Brito-Martins M, Harding SE, Ali NN: Beta(1)- and beta(2)- adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: Comparison with failing and non-failing adult human heart. Br J Pharmacol 2008; 153: 751-759
34. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, Huber I, Satin J, Itskovitz-Eldor J, Gepstein L: Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22: 1282-1289 (Pubitemid 39341201)
35. Sartiani L, Bettiol E, Stillitano F, Mugelli A, Cerbai E, Jaconi ME: Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: A molecular and electrophysiological approach. Stem Cells 2007; 25:1136-1144
36. Lough J, Sugi Y: Endoderm and heart development. Dev Dyn 2000; 217:327-342
37. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ, Keller GM: Human cardiovascular progenitor cells develop from a KD+ embryonic-stem-cell-derived population. Nature 2008; 453:524-528
38. Liu H, Dalton S, Xu Y: Transcriptional profiling of definitive endoderm derived from human embryonic stem cells. Comput Syst Bioinformatics Conf 2007; 6:79-82
39. Vanden Hoek TL, Qin Y, Wojcik K, Li CQ, Shao ZH, Anderson T, Becker LB, Hamann KJ: Reperfusion, not simulated ischemia, initiates intrinsic apoptosis injury in chick cardiomyocytes. Am J Physiol Heart Circ Physiol 2003; 284:H141-50
40. Marinovic J, Bosnjak ZJ, Stadnicka A: Distinct roles for sarcolemmal and mitochondrial adenosine triphosphatesensitive potassium channels in isoflurane-induced protection against oxidative stress. ANESTHESIOLOGY 2006; 105: 98-104
41. Tanaka K, Weihrauch D, Ludwig LM, Kersten JR, Pagel PS, Warltier DC: Mitochondrial adenosine triphosphate-regulated potassium channel opening acts as a trigger for isoflurane-induced preconditioning by generating reactive oxygen species. ANESTHESIOLOGY 2003; 98:935-943
42. Batandier C, Guigas B, Detaille D, El-Mir MY, Fontaine E, Rigoulet M, Leverve XM: The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin. J Bioenerg Biomembr 2006; 38: 33-42
43. Hanley PJ, Ray J, Brandt U, Daut J: Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 2002; 544: 687-693
44. Murphy E, Steenbergen C: Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88:581-609
45. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, Ovize M: Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005; 38:367-374 (Pubitemid 40215206)
46. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW, American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery), American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society for Vascular Surgery: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:e418 -99